No long-term changes in psoriasis severity and quality of life following climate therapy

Journal of the American Academy of Dermatology

Volumn 52, Issue 4, 2005, Pages 699-701

  Wahl, Astrid K ^a,d   Mørk, Cato ^b   Cooper, Bruce A ^c   Padilla, Geraldine ^c  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLIMATOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; SELF EVALUATION; SELF REPORT;

EID: 17844375945     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.01.117     Document Type: Article

References (18)

1. E. Snellman, J. Lauharanta, A. Reunanen, C.T. Jansen, T. Jyrkinen-Pakkasvirta, and M. Kallio Effect of heliotherapy on skin and joint symptoms in psoriasis: a 6 month follow-up study Br J Dermatol 128 1993 172 177
2. C. Mørk, and A.K. Wahl Improved quality of life among patients with psoriasis after supervised climate therapy at the Canary Islands J Am Acad Dermatol 47 2002 314 316
3. T. Fredriksson, and U. Pettersson Severe psoriasis-oral therapy with a new retinoid Dermatologica 157 1978 238 244
4. S.R. Feldman, A.B. Fleischer, D.M. Reboussin, S.R. Rapp, M.L. Exum, and A.R. Clark The self-administered psoriasis area and severity index is valid and reliable J Invest Dermatol 106 1996 183 186
5. A.B. Fleischer, S.R. Feldman, S.R. Rapp, D.M. Reboussin, M.L. Exum, and A.R. Clark Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores J Invest Dermatol 107 1996 26 29
6. A.B. Fleischer, S.R. Feldman, and C.L. Deckle The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial J Dermatol 26 1999 210 215
7. R.D. Hays, C.D. Sherbourne, and R.M. Mazel The RAND 36-Item Health Survey 1.0 Health Econ 2 1993 217 227
8. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 483
9. J.H. Loge, and S. Kaasa Short form 36 (SF-36) health survey: normative data from the general Norwegian population Scand J Soc Med 26 1998 250 258
10. G. Verbeke, and G. Molenberghs Linear Mixed Models for Longitudinal Data 2000 Springer-Verlag New York
11. L. Molin Climate therapy for Swedish psoriatics on HVAR Acta Derm Venereol (Stockh) 282 1972 155 160
12. W.W. Avrach Climatotherapy at the Dead Sea E.M. Farber A.J. Cox P.H. Jacobs M.L. Nail Psoriasis. Proceedings of the second international symposium 1977 Yorke Medical Books New York 258 263
13. U. Blick, and H. Angster Kalamnestiche untersuchungen zur behandlung der psoriasis am Toten Meer Prävention Rehabilitation 4 1992 37 41
14. D.J. Abels, Z. Even-Paz, and D. Efron Bioclimatology at the Dead Sea in Israel Clin Dermatol 14 1996 653 658
15. J. Shani, M. Harari, E. Hristakieve, V. Seidl, and J. Bar-Giyora Dead Sea climatotherapy versus other modalities of treatment for psoriasis: comparative cost-effectiveness Int J Dermatol 38 1999 252 262
16. H. Van Weelden, E. Young, and J.C. van der Leun Therapy of psoriasis: comparision of photochemotherapy and several variants of phototherapy Br J Dermatol 103 1980 1 9
17. J. Koo, and M. Lebwohl Duration of remission of psoriasis J Am Acad Dermatol 41 1999 51 59
18. G.G. Krueger, S.R. Feldman, C. Camisa, M. Duvic, J.T. Elder, and A.B. Gottlieb Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 43 2 pt 1 2000 281 285